Search Results 1781-1790 of 30984 for biopsy

1. A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis - Mayo Clinic

   Must have a biopsy unless data are available from a previous one. The biopsy ... Nerve biopsies are not required. Women of childbearing potential ...

2. Uterine Surgery Vaginal and Cervical Sampling - Mayo Clinic

   All ages with positive biopsies. Presence of uterus. Scheduled for ... Confirmed endometrial carcinoma on biopsy;; Benign conditions including, but ...

3. Spinal stenosis - Doctors and departments - Mayo Clinic

   esis surgery, Surgical biopsy, Tumor biopsy, Surgical stabilization of metastatic bone cancer, Tumor resection, Vertebral column resection, Pelvic tumor ...

4. Histology of Functional Density in Postmenopausal Breast - Mayo Clinic

   MBI performed less than one month prior to biopsy demonstrating either significant FD or photopenic FD. Exclusion criteria: Using any exogenous hormones ...

5. Study Evaluating the Safety, Tolerability, and Effectiveness of EDP-305 in Subjects with Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   NOTE: Vitamin E should not have been initiated after the date the biopsy was performed and subjects should have a stable weight since the liver biopsy was ...

6. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   Tissue available for biomarker testing (any brain metastasis tissue and extracranial site from any prior resection or biopsy). REGISTRATION ELIGIBILITY ...

7. Impact of Surgical Removal or Reduction Procedures on Markers of Immune Function in Adult Patients with Renal and Bladder Tumors and Pediatric Patients with Genitourinary Tumors - Mayo Clinic

   Open biopsy; Percutaneous biopsy; Resection of mass. Exclusion Criteria. Subjects ≥ 18 years of age: Bilateral tumors; Salvage procedure (i.e. treatment for a ...

8. Diagnostic and Prognostic Validity of Tissue-based Biomarker Assay for Acute Graft-versus-host Disease of the Skin: A Retrospective Study - Mayo Clinic

   Adults who have undergone hematopoietic cell transplantation, with skin biopsies ... Patients for whom ≥3 months follow-up information (or date of expiration, if ...

9. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) in Women with Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women with Recurrent or Persistent Endometrial Cancer” - Mayo Clinic

   ... biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy. Patients must have signed an approved informed consent ...

10. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

    ... biopsy; fine needle aspirations; Broviac line or infusaport placement; paracentesis or thoracocentesis. Please note: Lumbar punctures or placement of ...